Clinical Trial Update: Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma [Phase 1]

View source ↗

Summary

Clinical trial update on VS-5584 describes a Phase I dose-escalation study in patients with advanced non-hematologic malignancies or lymphoma. The trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• VS-5584

Snippet

Sponsor: Verastem, Inc. | Conditions: Non Hematologic Cancers, Metastatic Cancer | Phase 1 | Status: TERMINATED